Harry Janssen Selected Research

Hepatitis B e Antigens

1/2019	Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion.
10/2018	ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harry Janssen Research Topics

Disease

2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2021 - 01/2021
2	Chronic Hepatitis B 01/2019 - 10/2018
1	Cholestasis 01/2021
1	Liver Diseases (Liver Disease) 01/2008

Drug/Important Bio-Agent (IBA)

2	Hepatitis B e AntigensIBA 01/2019 - 10/2018
1	Alkaline PhosphataseIBA 12/2021
1	BilirubinIBA 12/2021
1	TransferasesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021
1	NucleotidesIBA 10/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2018

Therapy/Procedure

2	Therapeutics 10/2018 - 01/2008
1	Liver Transplantation 01/2021